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We report a patient with diffuse malignant pleural me-sothelioma (MPM) who underwent an extrapleural
pneumonectomy (EPP) and had marked leukocytosis during
the postoperative course. The level of serum granulocyte
colony-stimulating factor (G-CSF) was increased to 130
pg/ml (normal range, 8-30.5 pg/ml). The patient died of liver
and renal failure as a result of tumor progression on the 76th
postoperative day. Although the level of serum G-CSF before
the operation was within the normal limit (19 pg/ml), immu-
nohistochemistry of surgical specimens using a specific poly-
clonal antibody against G-CSF demonstrated that the cyto-
plasm of the tumor cells were positive. To the best of our
knowledge, only five cases of G-CSF-producing MPM, in-
cluding the current case, have been reported.
CASE REPORT
A previously healthy 49-year-old man was admitted
with a 2-month history of right chest pain and progressive
dyspnea on exertion. He was a train mechanic and had
worked with thermal insulants containing asbestos for 5 years
from 28 years old. Physical examination showed marked
reduction of breath sounds on the right side. Chest radiogra-
phy and computed tomographic scans revealed a massive
effusion in the right thorax and irregular pleural thickening.
Histopathological analyses of the pleural biopsy with video-
assisted thoracic surgery were consistent with the biphasic
type of MPM.
Laboratory findings revealed slight anemia (hemoglo-
bin level 12.1 g/dl), a normal platelet count of 37.0  104/l,
a normal white blood cell (WBC) count of 8,400 cells/l
(70% neutrophils), and slightly increased C-reactive protein
(CRP) of 5.8 mg/dl. Other hepatic and renal function data and
tumor markers in the serum were within the normal ranges.
There was no apparent distant metastasis, so clinical T2N0M0
according to the International Mesothelioma Interest Group
criteria was diagnosed. The patient underwent an extrapleural
pneumonectomy (EPP) of the right side with combined re-
section of the needle tract of the pleural biopsy. Histopatho-
logical analysis of the resected specimen indicated the bipha-
sic type of T3N2M0 MPM. During the postoperative course,
the WBC count and CRP had gradually increased without any
infectious bacterial event. Examination of bone marrow re-
vealed hypercellularity with no evidence of malignant cell
proliferation. On the 63rd postoperative day, the WBC count
increased to 50,000 cells/l (89.4% neutrophils), and the CRP
level was also high (16.4 g/dl). The serum concentration of
G-CSF was 130 pg/ml (normal range, 8-30.5 pg/ml). Com-
puted tomographic scans and positron emission tomography
with [F]-fluoro-2-deoxy-D-glucose revealed a local recur-
rence on the right chest wall and around the crura of the
diaphragm. Radiotherapy was planned, but the patient devel-
oped severe liver and renal failure resulting from tumor
progression and died on the 76th postoperative day. Immu-
nohistochemical analysis for G-CSF on the resected specimen
of the primary tumor showed that the cytoplasm of tumor
cells was positive for anti-human G-CSF polyclonal antibody
(PeproTech, London, UK) (Figure 1).
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FIGURE 1. Tumor cells were positive for anti-human granu-
locyte colony-stimulating factor polyclonal antibody. 200
magnification.
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DISCUSSION
In this case, the patient’s serum G-CSF level was
normal (19 pg/ml) before surgery but became markedly
increased during the postoperative course. Moreover, the
cytoplasm of resected tumor cells was immunohistochemi-
cally stained with anti-human G-CSF polyclonal antibody,
confirming that recurrent MPM cells might produce G-CSF.
Established human MPM cell lines in culture have been
found to produce G-CSF,1 and the first clinical case of a
G-CSF–producing MPM was reported in 1995.2 To the
present, only five Japanese patients with MPM, including the
current patient, have been demonstrated to produce G-CSF
(Table 1).2–5 All patients were male, with the mean age of
53.6 years (range, 45-65 years). The maximal WBC count
during the clinical course ranged from 50,000 to 85,100
cells/l. All but the present case received chemotherapy or
supportive care because of the advanced stage. Only our
current patient was treated with EPP and showed a markedly
increased serum G-CSF level during the postoperative phase.
In the reported five cases of G-CSF–producing MPM, the
short survival ranged from 4 to 89 weeks.
This is the first case report of G-CSF–producing MPM
that showed leukocytosis after an EPP. When leukocytosis was
found without bacteriological findings in the postoperative
course of MPM, we should consider the possibility of G-CSF–
producing MPM, which may suggest a poor prognosis.
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TABLE 1. Reported Cases of G-CSF–Producing MPM
Case Reference Age/Sex Histology
Maximum Leukocyte
Count (cells/l)
Serum G-CSF
Level (pg/ml) Treatment Survival (wk)
1 Rikimaru et al.2 45/M Epithelial 51,000 50 Chemotherapy 4
2 Ohbayashi et al.3 61/M Biphasic 85,100 67 Supportive care 29
3 Kasuga et al.4 48/M Desmoplastic 64,700 138 Chemotherapy 42
4 Yoshimoto et al.5 65/M Desmoplastic 53,600 36 Chemotherapy 89
5 Present case 49/M Biphasic 50,000 130 EPP 11
MPM, malignant pleural mesothelioma; G-CSF, granulocyte colony-stimulating factor; EPP, extrapleural pneumonectomy.
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